Gliomark

New Diagnostics for Gliomas

Navigation
Oktober 2016

Meet us at BioEUROPE in Cologne

The consortium will participate in Europe's largest partnering conference serving the global biotechnology industry, the BIO-Europe.
You may approach us through the partnering system of the conference. We look forward to discussing cooperations with you.

Orphan designation for Tetrofosmin

The consortium is pleased to announce that, on 14/10/2016 the European Commission has granted to proACTINA SA, Orphan Designation for tetrofosmin for the diagnosis of Glioma, following positive opinion by EMA. The product is registered in the “Community register of orphan medicinal products” with an EU orphan designation number: EU/3/16/1764.

This achievement has been one of the major milestones in GLIOMARK project.

See here the related press release.